COL18A1 and hypertensive disorder: A common side effect of treatment with inhibitors of angiogenesis is arterial hypertension,36 and Sunshine et al.16 proposed that co-administration of endostatin during antiangiogenesis therapy, e.g. VEGF inhibitors, may prevent the drug-induced hypertension.